X
20
Alkermes Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RAPAMYCIN NANOCRYSTAL COLLOIDAL DISPERSION-MEDIA MILLING PROCESS, with a corresponding US DMF Number 12571.
Remarkably, this DMF maintains an Active status since its submission on July 09, 1997, highlighting commitment to regulatory compliance.